109182
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
不同人群在新冠病毒感染易感性和严重程度方面的遗传风险
Authors Sun N , Lu Y, Li C, Jiang A, Liu L, Guo J
Received 5 August 2025
Accepted for publication 14 October 2025
Published 25 October 2025 Volume 2025:18 Pages 5499—5505
DOI https://doi.org/10.2147/IDR.S554153
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Alberto Ospina Stella
Ning Sun,1,* Yinglong Lu,2,3,* Conglin Li,1 Awei Jiang,2,3 Lei Liu,4 Jiubiao Guo2,3
1Guangzhou Cadre and Talent Health Management Center, Guangzhou 11th People’s Hospital, Guangzhou, People’s Republic of China; 2Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou, People’s Republic of China; 3Department of Pharmacology, Shantou University Medical College, Shantou, People’s Republic of China; 4Department of Infectious Diseases, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Jiubiao Guo, Email jbguo@stu.edu.cn Lei Liu, Email 513537271@qq.com
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has created challenges by threatening public health and triggering the largest global economic crisis in recent history. While environmental factors and social activities influence the clinical outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure and COVID-19 severity, the host genetic background and variants are increasingly recognized as vital players in individual susceptibility to SARS-CoV-2 infection, ranging from asymptomatic infection to lethal COVID-19. A plethora of genome-wide association meta-analyses have been provided and will continue to provide genetic determinants of the heterogeneity of COVID-19 outcomes. Such discoveries undoubtedly deepen our understanding of the biological underpinnings of SARS-CoV-2 infection and COVID-19 disease, paving the way for the development of more efficient SARS-CoV-2 prevention strategies and drug repurposing. Here, we provide a brief overview of studies regarding host susceptibility to COVID-19 and its clinical outcomes, focusing on the identification of genome-wide significant loci from different ancestral populations.
Keywords: COVID-19, SARS-CoV-2, genetic risk, susceptibility, severity, populations
1Guangzhou Cadre and Talent Health Management Center, Guangzhou 11th People’s Hospital, Guangzhou, People’s Republic of China; 2Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou, People’s Republic of China; 3Department of Pharmacology, Shantou University Medical College, Shantou, People’s Republic of China; 4Department of Infectious Diseases, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Jiubiao Guo, Email jbguo@stu.edu.cn Lei Liu, Email 513537271@qq.com
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has created challenges by threatening public health and triggering the largest global economic crisis in recent history. While environmental factors and social activities influence the clinical outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure and COVID-19 severity, the host genetic background and variants are increasingly recognized as vital players in individual susceptibility to SARS-CoV-2 infection, ranging from asymptomatic infection to lethal COVID-19. A plethora of genome-wide association meta-analyses have been provided and will continue to provide genetic determinants of the heterogeneity of COVID-19 outcomes. Such discoveries undoubtedly deepen our understanding of the biological underpinnings of SARS-CoV-2 infection and COVID-19 disease, paving the way for the development of more efficient SARS-CoV-2 prevention strategies and drug repurposing. Here, we provide a brief overview of studies regarding host susceptibility to COVID-19 and its clinical outcomes, focusing on the identification of genome-wide significant loci from different ancestral populations.
Keywords: COVID-19, SARS-CoV-2, genetic risk, susceptibility, severity, populations